Males and Females 18 years and older
The trial is being conducted to determine the safety and effectiveness of the medication zavegepant in the possible treatment of migraines.
The trial is being conducted to determine the safety and effectiveness of the medication zavegepant in the possible treatment of migraines.
The trial will last up to 24 weeks involving 9 visits to our office
Participants are paid $75 per completed office appointment.